FDA Approves INFLECTRA™ (Biosimilar Infliximab), The First U ... - Pfizer
https://www.pfizer.com:443/news/press-release/press-release-detail/fda_approves_inflectra_biosimilar_infliximab_the_first_u_s_biosimilar_monoclonal_antibody_for_all_eligible_indications
WEBApr 5, 2016 · NEW YORK--The United States (U.S.) Food and Drug Administration (FDA) today approved Celltrion’s INFLECTRA™ (biosimilar infliximab) across all eligible indications of the reference product, Remicade® (infliximab).1INFLECTRA is now the first and only biosimilar monoclonal antibody (mAb) therapy, and only the second biosimilar, …
DA: 48 PA: 95 MOZ Rank: 15